Phase I study of camrelizumab in patients with advanced solid tumors

被引：0
|
作者：
Yuxiang Ma
Jiaxin Cao
Yang Zhang
Qianwen Liu
Wenfeng Fang
Yunpeng Yang
Yuanyuan Zhao
Qing Yang
Hongyun Zhao
Li Zhang
机构：
[1] Sun Yat-sen University Cancer Center,Department of Clinical Research
[2] State Key Laboratory of Oncology in South China,Department of Medical Oncology
[3] Collaborative Innovation Center for Cancer Medicine,undefined
[4] Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy,undefined
[5] Sun Yat-sen University Cancer Center,undefined
[6] State Key Laboratory of Oncology in South China,undefined
[7] Collaborative Innovation Center for Cancer Medicine,undefined
[8] Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy,undefined
[9] Jiangsu Hengrui Medicine Co. Ltd,undefined
来源：
Signal Transduction and Targeted Therapy | / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors
    Lee, Keun-Wook
    Lee, Dae Ho
    Kang, Jin Hyoung
    Park, Joon Oh
    Kim, Se Hyun
    Hong, Yong Sang
    Kim, Seung Tae
    Oh, Do-Youn
    Bang, Yung-Jue
    ONCOLOGIST, 2018, 23 (02): : 155 - +
  • [42] A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors
    Kyriakopoulos, Christos E.
    Braden, Amy M.
    Kolesar, Jill M.
    Eickhoff, Jens C.
    Bailey, Howard H.
    Heideman, Jennifer
    Liu, Glenn
    Wisinski, Kari B.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (03) : 290 - 297
  • [43] A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors
    Witta, SE
    Gustafson, DL
    Pierson, AS
    Menter, A
    Holden, SN
    Basche, M
    Persky, M
    O'Bryant, CL
    Zeng, C
    Baron, A
    Long, ME
    Gibbs, A
    Kelly, K
    Bunn, PA
    Chan, DC
    Pallansch, P
    Eckhardt, SG
    CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7229 - 7237
  • [44] Phase I study of BPM 31510 (ubidecarenone) in patients with advanced solid tumors
    Shah, Manish A.
    Yu, Peter
    Narain, Niven
    Sarangarajan, Rangaprasad
    Kiebish, Michael
    Vishnudas, Vivek
    Sun, Yezhou
    Rodrigues, Leonardo
    Akmaev, Viatcheslav R.
    Brouwer, Susan
    Stevens, Janice
    Benaim, Ely
    Zinner, Ralph
    CANCER RESEARCH, 2015, 75
  • [45] A phase I study of topotecan and gemcitabine in advanced solid tumors
    Derek S. Serna
    Tanios Bekaii-Saab
    Eric H. Kraut
    Investigational New Drugs, 2011, 29 : 1390 - 1394
  • [46] A phase I study of topotecan and gemcitabine in advanced solid tumors
    Serna, Derek S.
    Bekaii-Saab, Tanios
    Kraut, Eric H.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1390 - 1394
  • [47] Phase I study of pemetrexed with sorafenib in advanced solid tumors
    Poklepovic, Andrew
    Gordon, Sarah
    Shafer, Danielle A.
    Roberts, John D.
    Bose, Prithviraj
    Geyer, Charles E., Jr.
    McGuire, William P.
    Tombes, Mary Beth
    Shrader, Ellen
    Strickler, Katie
    Quigley, Maria
    Wan, Wen
    Kmieciak, Maciej
    Massey, H. Davis
    Booth, Laurence
    Moran, Richard G.
    Dent, Paul
    ONCOTARGET, 2016, 7 (27): : 42625 - 42638
  • [48] Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
    Jones, S. F.
    Plummer, E. R.
    Burris, H. A.
    Razak, A. R.
    Meluch, A. A.
    Bowen, C. J.
    Williams, D. H.
    Hodge, J. P.
    Dar, M. M.
    Calvert, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 85S - 85S
  • [49] A phase I study of oral darinaparsin in patients (pts) with advanced solid tumors (AST).
    Camacho, Luis H.
    Senzer, Neil N.
    Harb, Wael A.
    Barrett, John A.
    Korth, Christopher Charles
    Astl, Dorothea
    Jac, Jaroslaw
    Youssoufian, Hagop
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors
    Rigas, JR
    Kris, MG
    Miller, VA
    Pisters, KMW
    Heelan, RT
    Grant, SC
    Fennelly, DW
    Chou, TC
    Sirotnak, FM
    ANNALS OF ONCOLOGY, 1999, 10 (05) : 601 - 603
12345